MARCAINE
What it isPeripheral sodium-channel-blocking amide anesthetic; regional and epidural anesthesia.
Why this oneIts duration outlasts lidocaine several-fold, and the liposomal form extends it further.
What limits it⚑ Inadvertent intravascular injection can cause refractory ventricular arrhythmia or arrest; lipid emulsion is the rescue treatment.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Local or regional anesthesia/analgesia (surgery, oral surgery, diagnostic/therapeutic and obstetrical procedures) | Adults | Individualized by block type and concentration (0.25%, 0.5%, 0.75%) | Lowest effective dose | Individualized (see labeling); single dose usually sufficient |
Renal Substantially excreted by the kidney; greater risk of adverse reactions in renal impairment
Hepatic Reduced dosing and increased monitoring for systemic toxicity in moderate to severe hepatic impairment (impaired metabolism), especially with repeat doses
Repeated doses may cause significant cumulative increases in plasma levels; allow adequate spacing
Pregnancy Contraindicated for obstetrical paracervical block; no adequate human data; local anesthetics rapidly cross the placenta and can cause maternal/fetal/neonatal toxicity.
Lactation Undefined
⚠ BOXED WARNING
Cost, est. cash$20–$1,000/procedure
Generic entry1986
Legacy pregnancy categoryC
Defining liabilityLocal tissue injury and inadvertent systemic exposure can cause seizures or cardiovascular toxicity.
